Plain-English translation of NCT06840002 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called combined with two standard chemotherapy drugs ( and ) for women whose ovarian cancer has returned after initial treatment. The study will check whether this medication combination is safe, how the body processes it, and whether it helps shrink or control the cancer.
Women whose ovarian cancer comes back after initial chemotherapy have limited treatment options. Researchers believe adding this new medication to standard chemotherapy might improve how well the treatment works and help patients live longer.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic regularly to receive the study medication () combined with two chemotherapy drugs through IV infusion. The trial will monitor your health closely with blood tests, imaging scans, and physical exams to check whether the treatment is working and to watch for any side effects. Your participation would continue as long as the treatment is helping and you are tolerating it well.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China